Overview
Developmental toxicity tests are critical for identifying substances that may interfere with prenatal development, including structural abnormalities, growth retardation, or functional deficits. These tests are mandated by global regulatory bodies to ensure the safety of pharmaceuticals, agrochemicals, and industrial compounds. Standardized protocols, such as OECD Test Guideline 414 or ICH S5(R3), outline study designs using pregnant animals exposed to test compounds during key developmental stages. Results inform risk assessments and labeling requirements, protecting public health and minimizing liability for manufacturers.
Key Features
Tests typically employ rodents (rats/mice) or rabbits due to their well-characterized reproductive biology and cost-effectiveness. Dosing occurs during organogenesis (days 6–15 in rodents), followed by cesarean section and detailed fetal examinations. Endpoints include teratogenicity (malformations), embryo-fetal lethality, and alterations to growth parameters. Advanced methods may incorporate in vitro models (e.g., embryonic stem cell tests) for screening, though in vivo studies remain the regulatory gold standard.
Application Areas
Pharmaceutical companies use these tests to comply with FDA/EMA requirements for new drug applications. Agrochemical producers submit data to the EPA or EFSA for pesticide registration. Industrial chemical evaluations under REACH or TSCA also rely on developmental toxicity data. Emerging applications include nanotechnology and endocrine disruptor research, where traditional protocols may require adaptations to address novel mechanisms of toxicity.
Precautions
False positives can arise from maternal toxicity (e.g., stress or malnutrition), necessitating careful dose selection. Species-specific metabolic differences may also affect human relevance, requiring supplementary data from alternative models. Ethical considerations drive efforts to reduce animal use via the 3Rs (Replacement, Reduction, Refinement). Regulatory acceptance of non-animal methods is increasing but remains limited for definitive risk assessment.
B2B Procurement Guide
When outsourcing developmental toxicity studies, prioritize CROs (Contract Research Organizations) with OECD GLP certification and audit-ready facilities. Confirm their experience with your substance class (e.g., small molecules vs. biologics). Budget for ancillary services like histopathology or toxicokinetics. Lead times often exceed 12 months due to animal breeding cycles and regulatory review phases. Negotiate flexible pricing for multi-study packages or pilot-scale evaluations.
Related Manufacturers
- 主营：成分分析、消字号申请、口罩检测项目、发育毒性试验、消毒产品检测、口罩盐性检测
- 主营：运输条件鉴定、毒理检测、化妆品功效评价、病毒杀灭试验、消毒产品检测、土壤检测、危废鉴别、涉水产品检测、空气净化产品检测、塑胶跑道检测、洁净室检测、抗菌防霉检测、产品质量鉴定、固废检测、成分分析、海洋测绘、海洋监测、消毒设备检测、化妆品检测、水处理剂检测、涂料检测、无尘车间检测